scholarly journals Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study

2018 ◽  
Vol 33 (8) ◽  
pp. 1397-1406 ◽  
Author(s):  
Michael R McClung ◽  
Jacques P Brown ◽  
Adolfo Diez-Perez ◽  
Heinrich Resch ◽  
John Caminis ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Phase 2 ◽  
Mineral Density ◽  
Double Blind ◽  
Low Bone Mineral Density ◽  
Parallel Group Study ◽  
Parallel Group

OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A136.2-A137 ◽  
Author(s):  
M. R. McClung ◽  
A. Grauer ◽  
S. Boonen ◽  
J. P. Brown ◽  
A. Diez-Perez ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Phase 2 ◽  
Mineral Density ◽  
Low Bone Mineral Density ◽  
Phase 2 Trial

scholarly journals Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

2012 ◽  
Vol 27 (11) ◽  
pp. 2251-2258 ◽  
Author(s):  
Bente Langdahl ◽  
Neil Binkley ◽  
Henry Bone ◽  
Nigel Gilchrist ◽  
Heinrich Resch ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Phase 2 ◽  
Mineral Density ◽  
Low Bone Mineral Density ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document